Animal Health

Medical Information and Pharmacovigilance Services

Comprehensive solutions for animal heath regulatory needs

Animal Health Experience & Capabilities

Global contact center support icon

24/7/365

Fully integrated, decentralized 24/7/365 contact center.

24/7/365

Fully integrated, decentralized 24/7/365 contact center.

Read Less
Expert Witness icon

FDA, NASC, EPA, USDA, PMRA

Experience helping clients maintain compliance with regulatory agencies.

FDA, NASC, EPA, USDA, PMRA

Experience helping clients maintain compliance with regulatory agencies.

Read Less
Patient support programs icon

Highly Qualified Experts

Our team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.

Highly Qualified Experts

Our team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.

Read Less
Document search icon

Animal Health Expertise

Animal Health Expertise

Product compliant intake icon

Toxicology Medical Information Contact Center

Toxicology Medical Information Contact Center

Medical writing icon

Medical Writing and Content Management

Medical Writing and Content Management

Global literature review icon

Pharmacovigilance Services

Pharmacovigilance Services

ProPharma’s Animal Health Expertise

ProPharma provides comprehensive Animal Health Medical Information (MI) and Pharmacovigilance (PV) support services, including expertise with the multiple regulatory environments that varied species and active ingredients require. ProPharma service comprises a fully integrated 24/7/365 contact center to deliver current and accurate information and improve patient health and safety as well as a team of PV experts to ensure the highest levels of compliance. ProPharma’s Animal Health team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals. This enables us to respond to medical inquiries in a manner that is not only consistent with product labeling and regulatory guidance, but also recognizes the connection between animals and people and the importance of communication between interdisciplinary healthcare professionals.

With a decentralized 24/7/365 contact center, ProPharma’s team of experts provides a customized solution to fit the medical information and pharmacovigilance needs of companies of all sizes. Whether you need to augment your internal team or need to completely outsource the Animal Health MI or PV functions globally, ProPharma has the right solution for your specific needs.

Veterinarian technician holding a cat

Animal Health & Toxicology Medical Information Contact Center

We offer comprehensive support around the clock. Our global 24/7/365 contact center provides crucial services, including Adverse Event (AE) intake and follow-up, Product Complaint (PC) management, and Medical Information inquiry fulfillment with escalation protocols. Our qualified MI/TOX specialists utilize market‐leading technologies to help clients deliver current and accurate information and improve patient health and safety.

We specialize in handling accidental exposure triage with thorough toxicology assessments and follow-up. Additionally, our team is adept at crisis detection and executing client emergency bullhorn actions, ensuring rapid and effective responses to urgent situations.

Our Animal Health team includes expertise with the multiple regulatory environments that varied species and active ingredients require, ensuring the highest levels of compliance. The team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.

Row of customer service professionals wearing headset one person smiling at camera

Animal Health Medical Writing and Content Management

Our team excels at medical writing and content management for your animal health products, leveraging our extensive expertise across various therapeutic areas and academic settings. We offer a range of services including standard document creation, custom response and content management, and response document maintenance. Additionally, our translation and localization services ensure that your critical documentation is accessible and relevant to diverse audiences.

Business worker holding espresso cup and stack of papers looking forward

Animal Health Pharmacovigilance Services

We ensure the highest standards of safety and compliance. Our services include comprehensive Adverse Drug Experience (ADE) assessment and processing, preparation and review of FDA Center for Veterinary Medicine (FDA CVM) ADE reports, and robust signal detection and management. We also offer seamless integration of regulatory services for non-FDA products, including but not limited to NASC, EPA/FIFRA, USDA, and Health Canada/PMRA, addressing all your pharmacovigilance needs.

Business professionals smiling at a desk reviewing data

Contact Us for Expert Animal Health Support 

We are dedicated to enhancing the health and well-being of animals through our comprehensive Medical Information and Pharmacovigilance services. Whether you need reliable medical information, safety monitoring, or compliance support, our team of experts is here to help.

Meet Our Animal Health Experts

  • Dane Goede Bio Photo

    Dane Goede

    Traditional Call Center Manager

    View Bio

  • Eric Battjes Bio Photo

    Eric Battjes

    Medical Information Specialist, Toxicologist

    View Bio

  • Karen Gjevre Bio Photo

    Karen Gjevre

    Medical Information Supervisor, Traditional Call Center

    View Bio

Dane Goede is a veterinarian and graduate-level researcher with extensive experience in epidemiology, public health, and food safety. With extensive research experience, multiple peer-reviewed publications, and numerous formal presentations, Dane excels in translating complex clinical information for the public. He is passionate about problem-solving and collaborating with colleagues and clients.
Eric Battjes is a veterinarian with a master’s degree in biomedical engineering and background in preclinical trials. He has been with ProPharma for over 12 years and has provided animal pharma services through most of his tenure, developing extensive experience managing and reporting adverse event cases. Additionally, he is a practiced resource for MI, PC, and AE intake and triage for a variety of animal-, human-, and extra-label product incidents.
Karen Gjevre is a veterinarian with considerable clinical experience in small animal, small ruminant, exotic pet and avian patients and is a published author in a peer-reviewed journal. She has strong attention to detail and extensive experience in medical information and pharmacovigilance protocol building, adverse event documentation, and submitting reports across a wide array of regulatory agencies.

News & Insights

Pros and Cons of Working with a CRO

July 31, 2025

Pros and Cons of Working with a CRO

Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Pros and Cons of Working with a CRO

July 31, 2025

Pros and Cons of Working with a CRO

Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow